Core Viewpoint - The signing of a global order for 10,000 humanoid robots marks a significant milestone in the humanoid robot industry, demonstrating the practical application of embodied intelligent humanoid robots in real-world scenarios [1] Company Role and Advantages - The company is the final delivery party for the 10,000 humanoid robots, focusing on the application in family care scenarios, leveraging its "Horizon Cloud Brain" technology for end-to-end application [3] - The company possesses significant technological advantages in hardware, particularly in flexible intelligent joints, which are crucial for the practical application of humanoid robots [3] Industry Impact - The order is expected to drive substantial commercialization in the embodied intelligent robot industry, moving beyond the verification stage to practical, scalable applications [4] - The company's ability to integrate cloud capabilities with practical applications positions it as a leader in the vertical and scalable application era of the humanoid robot industry [4] Future Strategic Directions - Family care is one of the key application areas, with the order indicating successful vertical application case studies, while the company is also pursuing applications in security patrol, medical testing, and education [5] - The company has secured additional orders in the medical sector and is collaborating with Huawei for cloud technology and infrastructure support, enhancing the foundation for large-scale applications [5][6] Project Developments - The company has received an order for 1,000 units of its "Tonghong" robotic dog, aimed at various patrol scenarios, showcasing its capability in different environments [6] - The collaboration with Meinian Health involves a large-scale order for intelligent medical testing services, with contracts nearing completion for demonstration applications [6]

Core Viewpoint - The signing of a global order for 10,000 humanoid robots marks a significant milestone in the humanoid robot industry, indicating a shift towards practical applications of embodied intelligence robots in real-world scenarios [1] Company Role and Advantages - The company is the final delivery party for the 10,000 robot order, focusing on the application of humanoid robots in family care scenarios, leveraging its "Horizon Cloud Brain" technology for end-to-end application [3] - The company possesses significant technological advantages in hardware, particularly in flexible intelligent joints, which enhances its capability for scene-based applications [3] Industry Impact - The order is expected to drive substantial commercialization in the embodied intelligence robot industry, moving beyond the validation stage to practical, scalable applications [4] - The company's cloud-based capabilities demonstrate its leadership in advancing the industry towards vertical, practical, and scalable applications [4] Future Strategic Directions - Family care is one of several application areas, with the company also pursuing applications in security patrol, medical testing, and education, indicating a broad strategy for industry-wide application [5] - The company has secured additional orders in the medical sector and is collaborating with Huawei for cloud technology and infrastructure support, enhancing the foundation for large-scale applications [5][6] Specific Projects and Orders - The company has received an order for 1,000 robotic dogs aimed at various patrol scenarios, showcasing its ability to adapt its technology for different environments [7] - The collaboration with Meinian Health involves a large-scale order for intelligent medical testing services, with contracts nearing completion for demonstration applications [7]

HONG KONG ROBOTICS GROUP HOLDING LIMITED 港仔機器人集團控股有限公司 (Incorporated in the Bermuda with limited liability) (Stock Code: 370) SHARE AWARD SCHEME (Adopted by an ordinary resolution passed at the annual general meeting held on [ ] September 2025) 1 _______________________________________________________ ________________________________________________________ | 1. | DEFINITIONS 1 | | --- | --- | | 2. | PURPOSE OF THE SHARE AWARD SCHEME 6 | | 3. | ELIGIBLE PARTICIPANTS OF THE SHARE AWARD SCHEME 6 | | 4. | DURA ...

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 0.24% to close at 25,104.61 points, and a total trading volume of HKD 239.49 billion [1] - The Hang Seng Tech Index was the worst performer, dropping 0.77% to 5,498.5 points [1] - Huatai Securities noted that the market is in a critical phase with a lack of trading themes and awaiting verification of significant domestic and overseas events, suggesting a window for position adjustment [1] Blue-Chip Stocks Performance - China Resources Power (00836) led the blue-chip decline, falling 5.9% to HKD 18.51, contributing a loss of 3.86 points to the Hang Seng Index [2] - The company reported a revenue of HKD 50.267 billion for the first half of 2025, a decrease of 1.67% year-on-year, and a profit attributable to shareholders of HKD 7.872 billion, down 15.92% [2] - Other notable blue-chip movements included China Biologic Products (01177) rising 3.49% and China Unicom (00762) increasing by 3.39% [2] Sector Highlights High-Speed Rail Infrastructure - Major technology stocks generally weakened, while high-speed rail infrastructure stocks performed well, with China CNR (01766) rising 5.85% and Times Electric (03898) increasing by 5.43% [3] - The National Railway Group announced a tender for 210 high-speed train sets, exceeding market expectations, indicating a positive outlook for the sector [3] Pharmaceutical Sector - The pharmaceutical sector saw most stocks rise, with Basilea Pharmaceutica (02616) increasing by 12.87% and Akeso (01167) rising by 10.04% [4] - The Chinese Premier emphasized the need for high-quality technological support and policy backing for the biopharmaceutical industry, aiming to enhance innovation and production of effective medicines [4] Stablecoin Concept Stocks - Stablecoin-related stocks were active, with ZhongAn Online (06060) rising 6.98% and Yao Cai Securities (01428) increasing by 5.75% [4] - Goldman Sachs reported a new expansion cycle for the stablecoin market, potentially reaching trillions of dollars, with payment applications being a key growth driver [6] Notable Stock Movements - Crystal International (02232) reached a new high, closing up 12.66% at HKD 6.85, reporting a revenue of USD 1.229 billion, a 12.4% increase year-on-year [7] - Hong Kong Robotics (00370) surged 12.86% after signing a significant order for 10,000 humanoid robots, marking a milestone in the industry [8] - Huazhu Group (01179) reported a total revenue of RMB 6.426 billion for Q2 2025, a 4.52% increase, with a net profit of RMB 1.544 billion, up 44.7% [9] - Great Wall Motors (02333) saw a rise of 6.45% following the launch of its new PHEV model, which received over 21,856 orders within 24 hours [10] - ZTE Corporation (00763) increased by 5.38%, with analysts highlighting its underestimated progress in AI and network business [11]

Core Viewpoint - 港仔机器人 has signed a groundbreaking agreement for the global delivery of 10,000 humanoid robots, marking a significant milestone in the humanoid robotics industry [1] Group 1: Company Developments - 港仔机器人 shares rose over 10%, reaching HKD 1.54 with a trading volume of HKD 32.84 million [1] - The company will be responsible for the research, development, production, and delivery of the humanoid robots, as well as the integration of the intelligent cloud platform with the robots [1] Group 2: Industry Impact - The agreement, signed on August 20, involves collaboration with Guangdong Tiantai Robotics, Shandong Future Robotics, and Shandong Future Data Technology, creating the largest order in the humanoid robotics sector [1] - The project aims to deliver at least 10,000 humanoid robots for home care by the end of 2026, with plans to develop the first prototype by 2025 and achieve mass production of 50,000 units in 2026 [1]

Core Insights - The company has signed a groundbreaking agreement for the global order of 10,000 embodied intelligent humanoid robots, marking a significant milestone in the humanoid robot industry [1][2] - The order is expected to be delivered by the end of 2026, with the company responsible for the development, production, and integration of the robots and their cloud platform [1] - The company has established strategic partnerships with various enterprises, indicating a strong market presence and potential for future growth [1][2] Group 1 - The order represents the largest scale in the humanoid robot industry, facilitating the commercialization of embodied intelligent humanoid robots [1][2] - The company aims to complete the prototype development of the first-generation product by 2025 and achieve mass production of 50,000 units by 2026 [1] - The company has leveraged its software and hardware advantages in the humanoid robot sector, enhancing its business layout since March [1] Group 2 - The company has also secured a procurement agreement for at least 1,000 embodied intelligent security robots, with a total contract value of 300 million RMB [2] - The humanoid robot sector is recognized as a strategic emerging industry, supported by national policies and local government initiatives [2] - The recent large-scale order reflects the growing market demand and the company's effective "order-driven" business model, which is expected to accelerate market growth [2]

吴卓谦先生已获委任为首席财务官、公司秘书及授权代表以代替何先生，自2025年8月13日起生效。 港仔机器人(00370)发布公告，由于集团工作分配，何瑜先生已辞任公司首席财务官、公司公司秘书及 根据香港联合交易所有限公司证券上市规则第3.05条所规定的公司授权代表，自2025年8月13日起生 效。何先生将于辞任后留效集团担任顾问，就发展提供专业建议。 ...

吴卓谦先生已获委任为首席财务官、公司秘书及授权代表以代替何先生，自2025年8月13日起生效。 智通财经APP讯，港仔机器人(00370)发布公告，由于集团工作分配，何瑜先生已辞任公司首席财务官、 公司公司秘书及根据香港联合交易所有限公司证券上市规则第3.05条所规定的公司授权代表，自2025年 8月13日起生效。何先生将于辞任后留效集团担任顾问，就发展提供专业建议。 ...

格隆汇8月13日丨港仔机器人(00370.HK)公告，何瑜辞任公司首席财务官、公司秘书及根据香港联合交 易所有限公司证券上市规则第3.05条所规定公司授权代表，自2025年8月13日起生效。吴卓谦获委任为 首席财务官、公司秘书及授权代表以代替何，自2025年8月13日起生效。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確 性或完整性亦不發表任何聲明，亦明確表示概不就因本公佈全部或任何部份內容而產生或因 倚賴該等內容而引致之任何損失承擔任何責任。 Hong Kong Robotics Group Holding Limited 港仔機器人集團控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：370） 更換首席財務官、公司秘書及授權代表 港仔機器人集團控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）之董事（「董事」）局 （「董事局」）謹此宣佈，由於本集團工作分配，何瑜先生（「何先生」）已辭任本公司首席財務官 （「首席財務官」）、本公司公司秘書（「公司秘書」）及根據香港聯合交易所有限公司（「聯交所」） 證券上市規則（「上市規則」）第3.05條所規定之本公司授權代表（「授權代表」），自二零二五年八 月十三日起生效。何先生將於辭任後留效本集團擔任顧問，就發展提供專業建議。 何先生已確認，彼與董事局並無意見分歧，且概無有關彼辭任之事宜須提請聯交所及本公司 股東垂注。 董事局進一步宣佈，吳卓謙先生（「吳先生」）已獲委任為首席財務官、公司秘書及授 ...